16.11.2005

Drug firms Roche and Gilead have set aside their differences and struck a deal over the production of Tamiflu, the main weapon against a flu pandemic.
The two companies have been in arbitration after Tamiflu inventor Gilead moved to break up a 1996 licensing agreement earlier this year.
Roche will pay Gilead $62.5 M (£36M) and royalties of between 14% and 22%.